Drug & intervention
fam-trastuzumab deruxtecan-nxki
RxCUI 2267574
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
2 shownConditions being studied
HER2-positive Metastatic Breast Cancer2Adenocarcinoma1Adenocarcinoma of Colon1Colo-rectal Cancer1Colon Cancer1Colonic Neoplasms1Colorectal Neoplasms1ctDNA Monitoring1ER Positive Breast Cancer1Estrogen Receptor Positive Tumor1HER-2 Protein Overexpression1HER2 Amplification1HER2 Gene Mutation1HER2 Low Breast Cancer1HER2 Low Breast Carcinoma1HER2 Mutant Non-small Cell Lung Cancer1HER2 Mutation-Related Tumors1HER2-negative Breast Cancer1HER2-positive Breast Cancer1Hormone Receptor Negative Breast Carcinoma1
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.